Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K14 | Q99558 | 12/20 | 0.55 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.55 |
| ▸ | PAK4 | O96013 | 8/20 | 0.46 |
| ▸ | PIKFYVE | Q9Y2I7 | 1/20 | 0.40 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.40 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11970498 | 1.00 | MAP3K14 (0.55) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL11970772 | 0.90 | MAP3K14 (0.57) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL11970794 | 0.88 | PAK4 (0.58) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL11970785 | 0.87 | PAK4 (0.58) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL11998952 | 0.87 | MAP3K14 (0.72) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL12001724 | 0.85 | MAP3K14 (0.41) | MAP3K14PRKD1PAK4PAK1PKN1 | |
| SCHEMBL16428522 | 0.85 | MAP3K14 (0.61) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL11970383 | 0.85 | MAP3K14 (0.61) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL11970776 | 0.85 | MAP3K14 (0.61) | MAP3K14PRKD1PAK4PIKFYVEPAK1 | |
| SCHEMBL11970854 | 0.81 | PAK4 (0.56) | MAP3K14PRKD1PAK4PIKFYVE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150038460-A1 | 6,5-Heterocyclic Propargylic Alcohol Compounds and Uses Therefor | GENENTECH, INC. (US) | 2015-02-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038460-A1 | 6,5-Heterocyclic Propargylic Alcohol Compounds and Uses Therefor | NFKB1, NFRKB, NFKBIA | MAP3K14 519/4885PRKD1 1505/4885PAK4 1856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.